Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Aug;144(2):571-577.
doi: 10.1378/chest.12-2768.

Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study

Philippe R Bauer  1 , Dante N Schiavo  2 , Thomas G Osborn  3 , David L Levin  4 , Jennifer St Sauver  5 , Andrew C Hanson  6 , Darrell R Schroeder  6 , Jay H Ryu  2
Affiliations

Influence of interstitial lung disease on outcome in systemic sclerosis: a population-based historical cohort study

Philippe R Bauer et al. Chest. 2013 Aug.

Abstract

Background: Interstitial lung disease (ILD) is a frequent complication of systemic sclerosis (SSc) and a major cause of SSc-related deaths. This study aimed to determine the influence of ILD on SSc in a population-based historical cohort study. The hypothesis was that patients with SSc who develop ILD have increased morbidity and mortality when compared with patients with SSc without ILD.

Methods: Using the record linkage system of the Rochester Epidemiology Project in Olmsted County, Minnesota, this study identified the incidence of SSc between 1980 and 2010 and point prevalence on December 31, 2010 and determined the progression of organ involvement and its influence on outcome.

Results: During the 30-year interval, we identified 64 incident cases of SSc: 57 women and seven men, median age 49.1 years (interquartile range [IQR], 39.8-67.6 years). There were 43 prevalent cases. ILD occurred in 19 cases, usually after the diagnosis of SSc (median, 2 years; IQR, 0-10 years), with only three cases occurring 6 to 24 months beforehand. Pulmonary arterial hypertension (PAH) was diagnosed in 14 cases, heart failure in 27 cases, and chronic kidney disease (CKD) in 21 cases. Seventeen patients died during the study period, with a median survival time after diagnosis of 22.9 years. ILD, PAH, and CKD were associated with an increased risk of death.

Conclusions: The incidence of ILD associated with SSc was relatively low in this population-based cohort. ILD appeared to be a contributing factor to mortality. Other factors, including age, PAH, and CKD, were also associated with poor outcome.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Flow diagram showing the number of individuals at each stage of study. Localized = localized form of scleroderma; preexistent = systemic sclerosis diagnosed before the study period.
Figure 2.
Figure 2.
Survival plot of incident cases of scleroderma (with 95% CI).
See this image and copyright information in PMC

References

    1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989-2003 - PubMed
    1. Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum. 1980;23(5):581-590 - PubMed
    1. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003;29(2):239-254 - PubMed
    1. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum. 2008;37(4):223-235 - PubMed
    1. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA., Jr Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum. 1997;40(3):441-445 - PubMed

Publication types